Steven Reichling - 28 Mar 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Financial Officer
Signature
/s/ Steve Reichling
Issuer symbol
AXDX
Transactions as of
28 Mar 2022
Transactions value $
$0
Form type
4
Filing time
30 Mar 2022, 17:13:59 UTC
Previous filing
14 May 2021
Next filing
06 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Award $0 +57.7K $0.00 57.7K 28 Mar 2022 Common Stock 57.7K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The reporting person received restricted stock units on March 28, 2022, which vest on April 26, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3 Not Applicable.